Description
Benefits
• Short term alleviation of situational anxiety and fear in dogs triggered by noise or owner departure
• Quick-acting formula takes effect within one hour
• Can be given as needed and re-dosed up to 3 times every 24 hours
• Dog remains fully functional
• Can be used in combination with behavioural modification program, but is not mandatory
• Makes like less stressful for the dog and the owner
• Liquid Formulation + Small dosing volume = Easy to administer
Description
TESSIE 0,3 MG/ML ORAL SOLUTION FOR DOGS
The active substance of Tessie® is tasipimidine, a selective alpha-2A adrenoceptor agonist. Alpha-2A adrenergic receptors are mainly found in the central nervous system (CNS). By binding this receptor, tasipimidine inhibits the release and, consequently, the action of noradrenaline on sympathetic neurons through a negative feedback mechanism. The reduction/block of noradrenaline-mediated neurotransmission in the CNS leads to anxiolysis.
In a fearful/anxious state, the physiological stress reaction is activated, which leads to an over activation of noradrenergic neurotransmission (increased release of noradrenaline in the locus coeruleus). Tessie® decreases the amount of noradrenaline in the locus coeruleus, and this causes a decrease of motor behaviour and signalling associated with distress.

Directions for Use
ADMINISTRATION: Tessie® is administered orally at a dose of 30μg/kg (0,1ml/kg).
STORAGE
The product should be stored in a refrigerator (2-8°C). It can be kept for short periods of time (up to 1 month in total) at room temperature (15-25°C). Keep the product in the outer carton in order to protect it from light.
The in-use shelf life (refrigerated) after the first removal of the cap: 12 months.
CONTRAINDICATIONS
Severe cardiovascular disorder, severe systemic disease, hypersensitivity to the active substance or to any of the excipients, obvious sedation from previous dosing.
SPECIAL PRECAUTIONS FOR USE
If the dog is sedated, do not leave the dog alone. The response may be reduced in extremely nervous animals. Avoid skin, eye or mucosal contact.
ADVERSE REACTIONS
Very common: lethargy and emesis. Common: Sedation, behavioural disorders, pale mucous membranes, ataxia, diarrhoea, urinary incontinence, nausea, gastroenteritis, polydipsia, leucopenia, hypersensitivity reactions, somnolence and anorexia.
USE DURING PREGNANCY OR LACTATION
Not recommended.
INTERACTION WITH OTHER MEDICINAL PRODUCTS
Other central nervous system depressants may potentiate the effects of tasipimidine.
Pack Sizes
Tessie® is presented in a glass bottle that contains 15 ml of the product. An oral syringe is included in the package for easy administration of the product.




Grooming
Healthcare